Matches in SemOpenAlex for { <https://semopenalex.org/work/W2791413347> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2791413347 endingPage "627" @default.
- W2791413347 startingPage "605" @default.
- W2791413347 abstract "Background: Tripterigium wilfordii glycosides (TWG) demonstrate paramount bioactive effectiveness in the management of many autoimmune diseases. However, its side effects on the hepatic, nephrotic, reproductive, and cardiovascular systems have limited its immense therapeutic potentials. Triptolide (TP) and Celastrol (CL), the leading bioactive as well as toxic constituents of TWG, have been widely studied. This review aims to summarize the key mechanisms that TWG trigger the toxic reactions and the precautionary measures that could prevent and reduce such reactions. Method: We undertook a systemic search of bibliographic databases for peer-reviewed research literature about the toxic mechanisms and pharmacokinetic profiles of TWG. The key points of screened papers were described and combined together to make up whole. Results: Totally 125 papers were referred in this paper, the majority were from Chinese academic associations. It has been reported that reactive oxygen species generation, mitochondrial respiratory chain inhibition, and metabolizing enzyme inhibition are the leading factors of the toxic reactions. The bioactive effects and toxicities of TWG are closely related to its metabolic profiles. It has been confirmed that TP and CL inhibit CYP450 and the transporters. This paper reviews and summarizes the pharmacokinetic parameters of TWG. Antioxidants, polymeric micelle and topical nanoparticle formulations have exhibited potentials in toxicity circumvention. Conclusion: A thorough understanding of the pharmacokinetic and toxicological characteristics of TWG combined with further in-depth study will enhance the efficacy and safety in using TWG, which would augment and improve its clinical application in the future. Keywords: Toxic mechanism, pharmacokinetics, tripterigium glycosides, triptolide, celastrol, metabolite." @default.
- W2791413347 created "2018-03-29" @default.
- W2791413347 creator A5017917541 @default.
- W2791413347 creator A5047148949 @default.
- W2791413347 creator A5050522161 @default.
- W2791413347 creator A5054446858 @default.
- W2791413347 creator A5061820434 @default.
- W2791413347 creator A5073792148 @default.
- W2791413347 creator A5073936967 @default.
- W2791413347 creator A5075597917 @default.
- W2791413347 creator A5078622313 @default.
- W2791413347 date "2018-07-09" @default.
- W2791413347 modified "2023-09-22" @default.
- W2791413347 title "Pharmacokinetic and Toxicological Characteristics of Tripterigium Glycosides and Their Derivatives" @default.
- W2791413347 doi "https://doi.org/10.2174/1389200219666180302152752" @default.
- W2791413347 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29512444" @default.
- W2791413347 hasPublicationYear "2018" @default.
- W2791413347 type Work @default.
- W2791413347 sameAs 2791413347 @default.
- W2791413347 citedByCount "25" @default.
- W2791413347 countsByYear W27914133472018 @default.
- W2791413347 countsByYear W27914133472019 @default.
- W2791413347 countsByYear W27914133472020 @default.
- W2791413347 countsByYear W27914133472021 @default.
- W2791413347 countsByYear W27914133472022 @default.
- W2791413347 countsByYear W27914133472023 @default.
- W2791413347 crossrefType "journal-article" @default.
- W2791413347 hasAuthorship W2791413347A5017917541 @default.
- W2791413347 hasAuthorship W2791413347A5047148949 @default.
- W2791413347 hasAuthorship W2791413347A5050522161 @default.
- W2791413347 hasAuthorship W2791413347A5054446858 @default.
- W2791413347 hasAuthorship W2791413347A5061820434 @default.
- W2791413347 hasAuthorship W2791413347A5073792148 @default.
- W2791413347 hasAuthorship W2791413347A5073936967 @default.
- W2791413347 hasAuthorship W2791413347A5075597917 @default.
- W2791413347 hasAuthorship W2791413347A5078622313 @default.
- W2791413347 hasConcept C112705442 @default.
- W2791413347 hasConcept C185592680 @default.
- W2791413347 hasConcept C190283241 @default.
- W2791413347 hasConcept C2777477808 @default.
- W2791413347 hasConcept C2781164371 @default.
- W2791413347 hasConcept C55493867 @default.
- W2791413347 hasConcept C71924100 @default.
- W2791413347 hasConcept C98274493 @default.
- W2791413347 hasConceptScore W2791413347C112705442 @default.
- W2791413347 hasConceptScore W2791413347C185592680 @default.
- W2791413347 hasConceptScore W2791413347C190283241 @default.
- W2791413347 hasConceptScore W2791413347C2777477808 @default.
- W2791413347 hasConceptScore W2791413347C2781164371 @default.
- W2791413347 hasConceptScore W2791413347C55493867 @default.
- W2791413347 hasConceptScore W2791413347C71924100 @default.
- W2791413347 hasConceptScore W2791413347C98274493 @default.
- W2791413347 hasIssue "7" @default.
- W2791413347 hasLocation W27914133471 @default.
- W2791413347 hasLocation W27914133472 @default.
- W2791413347 hasOpenAccess W2791413347 @default.
- W2791413347 hasPrimaryLocation W27914133471 @default.
- W2791413347 hasRelatedWork W1492229869 @default.
- W2791413347 hasRelatedWork W1964759623 @default.
- W2791413347 hasRelatedWork W1976890451 @default.
- W2791413347 hasRelatedWork W1998356222 @default.
- W2791413347 hasRelatedWork W2030336508 @default.
- W2791413347 hasRelatedWork W2056938528 @default.
- W2791413347 hasRelatedWork W2065023395 @default.
- W2791413347 hasRelatedWork W2132691174 @default.
- W2791413347 hasRelatedWork W2792371826 @default.
- W2791413347 hasRelatedWork W2945264506 @default.
- W2791413347 hasVolume "19" @default.
- W2791413347 isParatext "false" @default.
- W2791413347 isRetracted "false" @default.
- W2791413347 magId "2791413347" @default.
- W2791413347 workType "article" @default.